
Lactiga accepted into the MaRS portfolio
Lactiga was accepted as a health venture into the startup portfolio of MaRS Discovery District, North America’s largest urban innovation hub occupying 1.5 million square feet in downtown Toronto.
Lactiga was accepted as a health venture into the startup portfolio of MaRS Discovery District, North America’s largest urban innovation hub occupying 1.5 million square feet in downtown Toronto.
https://www.thestar.com/business/mars/2021/06/09/got-milk-covid-19-antibodies.html?rf
https://www.theglobeandmail.com/canada/article-can-antibodies-from-human-breast-milk-help-in-the-covid-19-fight/
Original Post PRINCETON, N.J.--(BUSINESS WIRE)--Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement ...
© Lactiga